{"name":"Apex Bioscience","slug":"apex-bioscience","ticker":"","exchange":"","domain":"","description":"Apex Bioscience is a biotechnology company focused on developing innovative therapeutic solutions, with a lead candidate in Phase 3 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5sLWZkMlNMQTNPTHJSa0dsdlEzZ210SE5ZMi00VzBNZ0oycXFXOFV1YzlkMWI2OVZVeFBEUm5mUlFBM0UwOEVVWlpWOUFmTnVhTjg5M2I4LXo5dUpDVU1PZnUwNEkta0g5cXRIZ1hzVkFObkVKNk9WaVBXV3A?oc=5","date":"2026-01-06","type":"pipeline","source":"Dignity Memorial","summary":"Ralph Eacret Obituary - Apex, NC - Dignity Memorial","headline":"Ralph Eacret Obituary - Apex, NC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPVHhUYzdjODNPSjVreEI4OGpOM3pSUUFhWTVUU1F1MWFmY3dybUdKekFjdURVM2VMbGwwdHNrcE1PYjdQUWFUR3NnMTQ1a3BRZnNwYmJRMFN3X1dPYldWcW54UERBekhuYW0yUEJfMUdvRlZhUi1WSmY4YlZzcHJtc05GVlpKYlFqOWNnaWx6Z2toWnVMV2w5ZXhtcHZMNWpid1lKLW8zUVZkY3FJNUExd3BLOW1mSzBTOVNpZGF1OGhta2s4V1p4ZFNiS29IbVk?oc=5","date":"2025-12-08","type":"trial","source":"Seeking Alpha","summary":"Cogent Biosciences, Inc. (COGT) Discusses Full SUMMIT and Positive APEX Trial Results in Systemic Mastocytosis at ASH Conference - Slideshow (NASDAQ:COGT) 2025-12-08 - Seeking Alpha","headline":"Cogent Biosciences, Inc. (COGT) Discusses Full SUMMIT and Positive APEX Trial Results in Systemic Mastocytosis at ASH Co","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQdHFTMktua1ROS1pKdXRQQ204RnhaU2NSWWlHZld2RHhUT3NxWHhiaW80SnRtOThUZlEtd0ZybmZIS3VlRm1qZGhROVJjNjdva0ZXTHoxdFFQNDBkcUZpb04tQXlkdlQ2WWRYWlFMZ3lmZEN2LUJIZ0JzUHpNMXFLYzZxNDNQQmJ3MEMzYXY4RlptNmRYMnc?oc=5","date":"2025-12-03","type":"trial","source":"Yahoo Finance","summary":"BioCryst Pharmaceuticals (BCRX): Valuation Check After Positive APeX-P Pediatric ORLADEYO Trial Update - Yahoo Finance","headline":"BioCryst Pharmaceuticals (BCRX): Valuation Check After Positive APeX-P Pediatric ORLADEYO Trial Update","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPLXNNUl9HY0c3bndCcUhNai1uWV9LVk1ITmJOMGRjSmhCODUwZ0RMaUNNSzdCa0xtb2FBYy1hN2FxQVRtcjhkZGJDa19ybWFZMl9IZjBoNXpEU0FzRVk0ZWJLZUpnM0tnaDV5a0V6MVVkX2lXazJnMkU4dWN4V3ZVOVo4SGltT01Zc3NaN1VfZVVZREFxck9aU0p2eGxzSl9feGc4VXZXRTcteU03akpwc3hkck00ZWZ5YU5EQTlORUtvcERCTXQwZVJvX0JuUmFrTmNsOVVrS2d6dm0tczRJUkJSN0tWX0JqOERqaHE0X0w4N3dENjAwVFhB?oc=5","date":"2025-11-03","type":"earnings","source":"GlobeNewswire","summary":"Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results - GlobeNewswire","headline":"Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1BN29EQUFlUzBfS2JJYW11YkZDR2RXYUVsNXdSeFo4SFprUktJSjhKV0txckNjMUJ4QmFsRTZnc0hMMDlaN1VNNEZ0ME5qcUpwdVQw?oc=5","date":"2025-07-07","type":"trial","source":"FirstWord Pharma","summary":"Cogent surges on Phase II success for mastocytosis drug hopeful - FirstWord Pharma","headline":"Cogent surges on Phase II success for mastocytosis drug hopeful","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPLWxvcWoxeDZKb1BqSGtUVG9Kck81TmVjU0VrN2JBS0FyRmNzaTJTNmxHSk8wcHRlU21icllNNlE0VTFMZGF2ZVRIOFllaHJNRXdneURscEVHZk1mZTc1ZlA4bEhENVJVSnhseGxiNGtuQU5aVl91YmQzTW1FcWFsZFUxQzdSd0U?oc=5","date":"2025-05-07","type":"pipeline","source":"Pharmaceutical Executive","summary":"Carnie Wilson Teams with Neurocrine Biosciences for TD Awareness Campaign - Pharmaceutical Executive","headline":"Carnie Wilson Teams with Neurocrine Biosciences for TD Awareness Campaign","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5yZ0RiQ3dZM1dtZE5xTjh4UFc3bUhnNWhQTkNrT1lFMjhKQnI2Wk5sNTJ1WXpCX0ZDazZXSzFwSDhweU11UnpOczEzMkpQMW5ORWZzemxvSlkzTmZ5dm5qTHRHdkZpZEFtdndFOEtYVU5zRVhMdjlpWlFjZ0M?oc=5","date":"2025-04-11","type":"trial","source":"Oncology Pipeline","summary":"BridgeBio enters the pan-KRAS game | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"BridgeBio enters the pan-KRAS game | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQdUFPMTVLNjZ0TVBkY1BGOHJoT2pJcXZpbmlUMEJ0WUZWVGt1R0x1dHk1UmNRLVFPdUk1N1lMWFBQM0h4dERBSGpOa2tEWUVDRHBwMHM0dG11eURPODlSdFB1cTJIUVdiTXUyMHlQM2hlVEFIY1RGTjVGSlN1cGp6MFRrT2VIdWhZRU9qbno2VnF5WVA4eTNrWW9qVQ?oc=5","date":"2025-03-27","type":"trial","source":"Oncology Pipeline","summary":"AACR 2025 preview – distressed biotechs seek redemption | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"AACR 2025 preview – distressed biotechs seek redemption | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNUUlPM2Q0N0tFTVpMVVBxdG9FYnc1enMxR0FLQnE1V0Y5c2hYODM1aEJ2RW1Kc3o2ZW53M0trbHNydVExVGFsZUh0X0VWb0pOUVJlYkU0dDVMcm96VGJFMDVnbk02dXZSR0l0UzBKRllUMllsblQwNE5VNFl6SVRLVHBpdUU?oc=5","date":"2025-03-20","type":"trial","source":"Oncology Pipeline","summary":"Elevation goes down on Claudin disaster | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Elevation goes down on Claudin disaster | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQc2N5VjBLTjRfSTdjVmVaUlo2a0tHejdpc0haZzBCNGxEbjVZTUhQNFJKenNzc3p6RWFfODAxN1lYNGplQVJEdTAxWkdEamJRcTh3Y0xOWnhGem1SQ2tlcVVDYjBGQmx5cUZTNFU5ZGVvNVAycWJxOXZRSTdIRktUTA?oc=5","date":"2025-01-22","type":"trial","source":"Oncology Pipeline","summary":"Innate challenges Pfizer in Nectin-4 | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Innate challenges Pfizer in Nectin-4 | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1tbHA0bE5WMzd5Z0NBZnpGbkE4ZkxwWE5uZmdQOURuLVc1V1R5bElyLXZYcUdObEhZQ3NIdXFOVHVILTV6cEdmV3BRSDVFWmZTVFZCQ25udi1JbnpXYkxHTFZBOGNnc0VoZkEyZWFfZEZqZnM0c3FQa2lJZ0w?oc=5","date":"2024-04-23","type":"trial","source":"Oncology Pipeline","summary":"Anktiva’s tortuous journey ends | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Anktiva’s tortuous journey ends | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQYmZ0R3FjX0huODJxZWRHY0lkOW9GOE5NSDN5eXlKWjNsUHp4TUFwZ1gxV2dZd1hrYmxyRndDVWJCN2w0UkdQSFA2M1FfRWJhOTNYTlVPbnlLOTV4VEpzMnhzdVE4T0tWWUJrb1BUbkNHekx2Q2I3Wm9OWDU3RFJvb3VqZjBnQQ?oc=5","date":"2023-10-18","type":"pipeline","source":"Pharmaceutical Executive","summary":"2023 Pharmaceutical Executive APEX Award Winners - Pharmaceutical Executive","headline":"2023 Pharmaceutical Executive APEX Award Winners","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}